{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T23:34:13Z","timestamp":1761694453017,"version":"build-2065373602"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,28]]},"DOI":"10.7759\/cureus.95614","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T20:06:57Z","timestamp":1761682017000},"source":"Crossref","is-referenced-by-count":0,"title":["The Association Between Cytomegalovirus Infection and Increased Leukemia Incidence: A Retrospective Matched Cohort"],"prefix":"10.7759","author":[{"given":"Ernesto","family":"Joubran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily","family":"Tehrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"Ilyaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Tashjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aneil","family":"Walizada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manell","family":"Aboutaleb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"German","family":"Giese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"SEER Cancer Stat Facts. Leukemia. National Cancer Institute. (2025). Accessed: September 1, 2025: https:\/\/seer.cancer.gov\/statfacts\/html\/leuks.html."},{"key":"ref2","unstructured":"Key statistics for acute myeloid leukemia (AML). American Cancer Society. (2025). Accessed. September 1, 2025: https:\/\/www.cancer.org\/cancer\/types\/acute-myeloid-leukemia\/about\/key-statistics.html."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-08-752170","article-title":"Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation","volume":"131","author":"Cooley S","year":"2018","unstructured":"Cooley S, Parham P, Miller JS. Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation. Blood. 2018, 131:1053-62. 10.1182\/blood-2017-08-752170","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13152","article-title":"Cytomegalovirus: an unlikely ally in the fight against blood cancers?","volume":"193","author":"Bigley AB","year":"2018","unstructured":"Bigley AB, Baker FL, Simpson RJ. Cytomegalovirus: an unlikely ally in the fight against blood cancers?. Clin Exp Immunol. 2018, 193:265-74. 10.1111\/cei.13152","journal-title":"Clin Exp Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-07-2974","article-title":"Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer","volume":"105","author":"Miller JS","year":"2005","unstructured":"Miller JS, Soignier Y, Panoskaltsis-Mortari A, et al.. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood. 2005, 105:3051-7. 10.1182\/blood-2004-07-2974","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07340.x","article-title":"Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation","volume":"143","author":"Shi J","year":"2008","unstructured":"Shi J, Tricot G, Szmania S, et al.. Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation. Br J Haematol. 2008, 143:641-53. 10.1111\/j.1365-2141.2008.07340.x","journal-title":"Br J Haematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7150\/jca.5049","article-title":"Clinical relevance of natural killer cells following hematopoietic stem cell transplantation","volume":"4","author":"Palmer JM","year":"2013","unstructured":"Palmer JM, Rajasekaran K, Thakar MS, Malarkannan S. Clinical relevance of natural killer cells following hematopoietic stem cell transplantation. J Cancer. 2013, 4:25-35. 10.7150\/jca.5049","journal-title":"J Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-015-1694-4","article-title":"Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A","volume":"64","author":"Sarkar S","year":"2015","unstructured":"Sarkar S, van Gelder M, Noort W, et al.. Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A. Cancer Immunol Immunother. 2015, 64:951-63. 10.1007\/s00262-015-1694-4","journal-title":"Cancer Immunol Immunother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1110900108","article-title":"Expansion of a unique CD57\u207aNKG2Chi natural killer cell subset during acute human cytomegalovirus infection","volume":"108","author":"Lopez-Verg\u00e8s S","year":"2011","unstructured":"Lopez-Verg\u00e8s S, Milush JM, Schwartz BS, et al.. Expansion of a unique CD57\u207aNKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci U S A. 2011, 108:14725-32. 10.1073\/pnas.1110900108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-304121","article-title":"Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients","volume":"118","author":"Elmaagacli AH","year":"2011","unstructured":"Elmaagacli AH, Steckel NK, Koldehoff M, et al.. Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood. 2011, 118:1402-12. 10.1182\/blood-2010-08-304121","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-487074","article-title":"CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia","volume":"122","author":"Green ML","year":"2013","unstructured":"Green ML, Leisenring WM, Xie H, et al.. CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia. Blood. 2013, 122:1316-24. 10.1182\/blood-2013-02-487074","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.260","article-title":"CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT","volume":"30","author":"Cichocki F","year":"2016","unstructured":"Cichocki F, Cooley S, Davis Z, et al.. CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT. Leukemia. 2016, 30:456-63. 10.1038\/leu.2015.260","journal-title":"Leukemia"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-10-4113","article-title":"NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect","volume":"105","author":"Nguyen S","year":"2005","unstructured":"Nguyen S, Dhedin N, Vernant JP, et al.. NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. Blood. 2005, 105:4135-42. 10.1182\/blood-2004-10-4113","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2014.12.027","article-title":"Acute exercise preferentially redeploys NK-cells with a highly-differentiated phenotype and augments cytotoxicity against lymphoma and multiple myeloma target cells. Part II: impact of latent cytomegalovirus infection and catecholamine sensitivity","volume":"49","author":"Bigley AB","year":"2015","unstructured":"Bigley AB, Rezvani K, Pistillo M, et al.. Acute exercise preferentially redeploys NK-cells with a highly-differentiated phenotype and augments cytotoxicity against lymphoma and multiple myeloma target cells. Part II: impact of latent cytomegalovirus infection and catecholamine sensitivity. Brain Behav Immun. 2015, 49:59-65. 10.1016\/j.bbi.2014.12.027","journal-title":"Brain Behav Immun"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12785","article-title":"Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans","volume":"185","author":"Bigley AB","year":"2016","unstructured":"Bigley AB, Rezvani K, Shah N, et al.. Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans. Clin Exp Immunol. 2016, 185:239-51. 10.1111\/cei.12785","journal-title":"Clin Exp Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-19-0044","article-title":"Early infection with cytomegalovirus and risk of childhood hematologic malignancies","volume":"28","author":"Wiemels JL","year":"2019","unstructured":"Wiemels JL, Talb\u00e4ck M, Francis S, Feychting M. Early infection with cytomegalovirus and risk of childhood hematologic malignancies. Cancer Epidemiol Biomarkers Prev. 2019, 28:1024-7. 10.1158\/1055-9965.EPI-19-0044","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-07-723148","article-title":"In utero cytomegalovirus infection and development of childhood acute lymphoblastic leukemia","volume":"129","author":"Francis SS","year":"2017","unstructured":"Francis SS, Wallace AD, Wendt GA, et al.. In utero cytomegalovirus infection and development of childhood acute lymphoblastic leukemia. Blood. 2017, 129:1680-4. 10.1182\/blood-2016-07-723148","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1593\/neo.81178","article-title":"The story of human cytomegalovirus and cancer: increasing evidence and open questions","volume":"11","author":"Michaelis M","year":"2009","unstructured":"Michaelis M, Doerr HW, Cinatl J. The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia. 2009, 11:1-9. 10.1593\/neo.81178","journal-title":"Neoplasia"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2010.10.026","article-title":"Is HCMV a tumor promoter?","volume":"157","author":"Soroceanu L","year":"2011","unstructured":"Soroceanu L, Cobbs CS. Is HCMV a tumor promoter?. Virus Res. 2011, 157:193-203. 10.1016\/j.virusres.2010.10.026","journal-title":"Virus Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/v10080408","article-title":"The human cytomegalovirus, from oncomodulation to oncogenesis","volume":"10","author":"Herbein G","year":"2018","unstructured":"Herbein G. The human cytomegalovirus, from oncomodulation to oncogenesis. Viruses. 2018, 10:8. 10.3390\/v10080408","journal-title":"Viruses"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson ME","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, et al.. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40:373-83. 10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1114966108","article-title":"Human cytomegalovirus activation of ERK and myeloid cell leukemia-1 protein correlates with survival of latently infected cells","volume":"109","author":"Reeves MB","year":"2012","unstructured":"Reeves MB, Breidenstein A, Compton T. Human cytomegalovirus activation of ERK and myeloid cell leukemia-1 protein correlates with survival of latently infected cells. Proc Natl Acad Sci U S A. 2012, 109:588-93. 10.1073\/pnas.1114966108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008037","article-title":"Host signaling and EGR1 transcriptional control of human cytomegalovirus replication and latency","volume":"15","author":"Buehler J","year":"2019","unstructured":"Buehler J, Carpenter E, Zeltzer S, et al.. Host signaling and EGR1 transcriptional control of human cytomegalovirus replication and latency. PLoS Pathog. 2019, 15:e1008037. 10.1371\/journal.ppat.1008037","journal-title":"PLoS Pathog"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11817","article-title":"Human cytomegalovirus encoded chemokine receptor US28 activates the HIF-1\u03b1\/PKM2 axis in glioblastoma cells","volume":"7","author":"de Wit RH","year":"2016","unstructured":"de Wit RH, Muji\u0107-Deli\u0107 A, van Senten JR, Fraile-Ramos A, Siderius M, Smit MJ. Human cytomegalovirus encoded chemokine receptor US28 activates the HIF-1\u03b1\/PKM2 axis in glioblastoma cells. Oncotarget. 2016, 7:67966-85. 10.18632\/oncotarget.11817","journal-title":"Oncotarget"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/413401-the-association-between-cytomegalovirus-infection-and-increased-leukemia-incidence-a-retrospective-matched-cohort","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T20:06:58Z","timestamp":1761682018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/413401-the-association-between-cytomegalovirus-infection-and-increased-leukemia-incidence-a-retrospective-matched-cohort"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.95614","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,10,28]]}}}